Cargando…

IGH::CD274 (PD‐L1) rearrangement in diffuse large B cell lymphoma and its therapeutic implication

Diffuse large B cell lymphoma (DLBCL) expresses abundant programmed death ligand 1 (PD‐L1), which shields tumor cells from immune attacks through the PD‐L1/PD‐1 signaling axis. The mechanism of PD‐L1 overexpression includes the deletion of the 3′end of PD‐L1, which increases its mRNA stability, and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wu, Xuemei, Chen, Si, Chen, Ping, Zhang, Han, Zhang, Liying, Wang, Panjun, Li, Bingzong, Rong, Rong, Wang, Yiting, Lang, Xingping, Wang, Kai, Zhang, Xiaohui, Xiao, Sheng
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2023
Materias:	Short Reports
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10188474/ https://www.ncbi.nlm.nih.gov/pubmed/37206267 http://dx.doi.org/10.1002/jha2.693

Ejemplares similares

Plasmablastic lymphoma with MYC::IGH fusion and BCL2 rearrangement
por: Barouqa, Mohammad, et al.
Publicado: (2022)

IgH gene rearrangements as plasma biomarkers in Non-Hodgkin's Lymphoma patients
por: He, Jian, et al.
Publicado: (2011)

Submicroscopic Deletions of Immunoglobulin Heavy Chain Gene (IGH) in Precursor B Lymphoblastic Leukemia with IGH Rearrangements
por: Huh, Jungwon, et al.
Publicado: (2015)

Mevalonate improves anti-PD-1/PD-L1 efficacy by stabilizing CD274 mRNA
por: Zhang, Wenxin, et al.
Publicado: (2023)

B-ALL With t(5;14)(q31;q32); IGH-IL3 Rearrangement and Eosinophilia: A Comprehensive Analysis of a Peculiar IGH-Rearranged B-ALL
por: Fournier, Benjamin, et al.
Publicado: (2019)

Intragenic β-synuclein rearrangements in malignancy
por: Xiao, Peifang, et al.
Publicado: (2023)

Multiple productive IGH rearrangements denote oligoclonality even in immunophenotypically monoclonal CLL
por: Brazdilova, K, et al.
Publicado: (2018)

Case report: Identification of atypical mantle cell lymphoma with CCND3 rearrangement by next-generation sequencing
por: Dai, Luomengjia, et al.
Publicado: (2023)

Oncogenic role of the SOX9-DHCR24-cholesterol biosynthesis axis in IGH-BCL2(+) diffuse large B-cell lymphomas
por: Shen, Yajie, et al.
Publicado: (2022)

Minimal Residual Disease Detection and Evolved IGH Clones Analysis in Acute B Lymphoblastic Leukemia Using IGH Deep Sequencing
por: Wu, Jinghua, et al.
Publicado: (2016)

IGH amplification in patients with B cell lymphoma unclassifiable, with features intermediate between diffuse large B cell lymphoma and Burkitt’s lymphoma
por: Bellone, Michael, et al.
Publicado: (2014)

Structural basis of DUX4/IGH-driven transactivation
por: Dong, Xue, et al.
Publicado: (2018)

Genetic features of precursor B‐cell phenotype Burkitt leukemia with IGH‐ MYC rearrangement
por: Yoshida, Masanori, et al.
Publicado: (2021)

Pan-cancer landscape of CD274 (PD-L1) rearrangements in 283,050 patient samples, its correlation with PD-L1 protein expression, and immunotherapy response
por: Kelly, Andrew D, et al.
Publicado: (2021)

Histopathological and genotypic characterization of metastatic colorectal carcinoma with PD‐L1 (CD274)‐expression: Possible roles of tumour micro environmental factors for CD274 expression
por: Inaguma, Shingo, et al.
Publicado: (2017)

Elucidating a false-negative MYC break-apart fluorescence in situ hybridization probe study by next-generation sequencing in a patient with high-grade B-cell lymphoma with IGH/MYC and IGH/BCL2 rearrangements
por: Peterson, Jess F., et al.
Publicado: (2019)

PB1913: IGH 3’RR RECOMBINATION UNCOVERS A NON-GC IMPRINT AND C-MYC-DEPENDENT IGH REARRANGEMENT ACTIVITY IN UNMUTATED CHRONIC LYMPHOCYTIC LEUKEMIA
por: Jamal, Israa Al, et al.
Publicado: (2023)

Recurrent Novel P2RY8/IGH Translocations in B-Lymphoblastic Leukemia/Lymphoma
por: Fang, Yanglan, et al.
Publicado: (2022)

Relationship of PD-1 (PDCD1) and PD-L1 (CD274) Single Nucleotide Polymorphisms with Polycystic Ovary Syndrome
por: Han, Rui, et al.
Publicado: (2021)

Critical roles of the immunoglobulin intronic enhancers in maintaining the sequential rearrangement of IgH and Igk loci
por: Inlay, Matthew A., et al.
Publicado: (2006)

Novel rearrangements at the immunoglobulin D locus. Inversions and fusions add to IgH somatic diversity
Publicado: (1989)

IGH Rearrangement Evolution in Adult KMT2A-rearranged B-cell Precursor ALL: Implications for Cell-of-origin and MRD Monitoring
por: Darzentas, Franziska, et al.
Publicado: (2022)

SOX11 expression as a MRD molecular marker for MCL in comparison with t(11;14) and IGH rearrangement
por: Szostakowska, Małgorzata, et al.
Publicado: (2018)

Nanopore sequencing of clonal IGH rearrangements in cell-free DNA as a biomarker for acute lymphoblastic leukemia
por: Sampathi, Shilpa, et al.
Publicado: (2022)

Association of PIK3CA mutation and PTEN loss with expression of CD274 (PD-L1) in colorectal carcinoma
por: Ugai, Tomotaka, et al.
Publicado: (2021)

Different Induction of PD-L1 (CD274) and PD-1 (CD279) Expression in THP-1-Differentiated Types 1 and 2 Macrophages
por: Lai, Chun-Yi, et al.
Publicado: (2021)

Inhibition of yes‐associated protein down‐regulates PD‐L1 (CD274) expression in human malignant pleural mesothelioma
por: Hsu, Ping‐Chih, et al.
Publicado: (2018)

Next generation sequencing of the clonal IGH rearrangement detects ongoing mutations and interfollicular trafficking in in situ follicular neoplasia
por: Kosmidis, Perikles, et al.
Publicado: (2017)

Identification and characterization of novel CD274 (PD‐L1) regulating microRNAs and their functional relevance in melanoma
por: Vaxevanis, Christoforos K., et al.
Publicado: (2022)

Enhancer RNA AL928768.3 from the IGH Locus Regulates MYC Expression and Controls the Proliferation and Chemoresistance of Burkitt Lymphoma Cells with IGH/MYC Translocation
por: Stasevich, Ekaterina Mikhailovna, et al.
Publicado: (2022)

Increased expression of the immune modulatory molecule PD-L1 (CD274) in anaplastic meningioma
por: Du, Ziming, et al.
Publicado: (2014)

Inverse relationship between Fusobacterium nucleatum amount and tumor CD274 (PD‐L1) expression in colorectal carcinoma
por: Ugai, Tomotaka, et al.
Publicado: (2023)

Double-Hit Primary Plasma Cell Leukemia with IGH/MYC and IGH/CCND1 Translocations
por: Yasumi, Masato, et al.
Publicado: (2020)

CNOT3 contributes to early B cell development by controlling Igh rearrangement and p53 mRNA stability
por: Inoue, Takeshi, et al.
Publicado: (2015)

Health Tract, No. 274: Bodily Strength
Publicado: (1867)

Gene code CD274/PD-L1: from molecular basis toward cancer immunotherapy
por: Fabrizio, Federico Pio, et al.
Publicado: (2018)

PD-L1 (CD274) promoter hypomethylation predicts immunotherapy response in metastatic urothelial carcinoma
por: Klümper, Niklas, et al.
Publicado: (2023)

Contribution of the IGCR1 regulatory element and the 3′Igh CTCF-binding elements to regulation of Igh V(D)J recombination
por: Liang, Zhuoyi, et al.
Publicado: (2023)

Long-read sequencing unveils IGH-DUX4 translocation into the silenced IGH allele in B-cell acute lymphoblastic leukemia
por: Tian, Liqing, et al.
Publicado: (2019)

Exploring tumor clonal evolution in bone marrow of patients with diffuse large B-cell lymphoma by deep IGH sequencing and its potential relevance in relapse
por: Ma, Jiao, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_oro3hditmh7eb3mt6u2736tc7p